» Articles » PMID: 26814432

Paracrine Effect of GTP Cyclohydrolase and Angiopoietin-1 Interaction in Stromal Fibroblasts on Tumor Tie2 Activation and Breast Cancer Growth

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Jan 28
PMID 26814432
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer-associated fibroblasts (CAFs) play a key role in promoting tumor growth, acting through complex paracrine regulation. GTP cyclohydrolase (GTPCH) expression for tetrahydrobiopterin synthesis in tumor stroma is implicated in angiogenesis and tumor development. However, the clinical significance of GTPCH expression in breast cancer is still elusive and how GTPCH regulates stromal fibroblast and tumor cell communication remains unknown. We found that GTPCH was upregulated in breast CAFs and epithelia, and high GTPCH RNA was significantly correlated with larger high grade tumors and worse prognosis. In cocultures, GTPCH expressing fibroblasts stimulated breast cancer cell proliferation and motility, cancer cell Tie2 phosphorylation and consequent downstream pathway activation. GTPCH interacted with Ang-1 in stromal fibroblasts and enhanced Ang-1 expression and function, which in turn phosphorylated tumor Tie2 and induced cell proliferation. In coimplantation xenografts, GTPCH in fibroblasts enhanced tumor growth, upregulating Ang-1 and alpha-smooth muscle actin mainly in fibroblast-like cells. GTPCH inhibition resulted in the attenuation of tumor growth and angiogenesis. GTPCH/Ang-1 interaction in stromal fibroblasts and activation of Tie2 on breast tumor cells could play an important role in supporting breast cancer growth. GTPCH may be an important mechanism of paracrine tumor growth and hence a target for therapy in breast cancer.

Citing Articles

New role for GCH1 in cancer.

Cronin S Transl Breast Cancer Res. 2024; 5:16.

PMID: 38751681 PMC: 11093062. DOI: 10.21037/tbcr-23-53.


Macrophage-derived SHP-2 inhibits the metastasis of colorectal cancer via Tie2-PI3K signals.

Wu X, Guan S, Lu Y, Xue J, Yu X, Zhang Q Oncol Res. 2023; 31(2):125-139.

PMID: 37304233 PMC: 10207961. DOI: 10.32604/or.2023.028657.


Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer.

Qi X, Wan Z, Jiang B, Ouyang Y, Feng W, Zhu H Front Immunol. 2022; 13:1038225.

PMID: 36505465 PMC: 9730886. DOI: 10.3389/fimmu.2022.1038225.


Disruption of Redox Homeostasis by Alterations in Nitric Oxide Synthase Activity and Tetrahydrobiopterin along with Melanoma Progression.

Soares J, Goncalves D, de Sousa R, Mouro M, Higa E, Sperandio L Int J Mol Sci. 2022; 23(11).

PMID: 35682659 PMC: 9181279. DOI: 10.3390/ijms23115979.


Construction and Verification of a Combined Hypoxia and Immune Index for Clear Cell Renal Cell Carcinoma.

Wang B, Liu L, Wu J, Mao X, Fang Z, Chen Y Front Genet. 2022; 13:711142.

PMID: 35222525 PMC: 8863964. DOI: 10.3389/fgene.2022.711142.


References
1.
Walter-Yohrling J, Cao X, Callahan M, Weber W, Morgenbesser S, Madden S . Identification of genes expressed in malignant cells that promote invasion. Cancer Res. 2003; 63(24):8939-47. View

2.
Brunckhorst M, Xu Y, Lu R, Yu Q . Angiopoietins promote ovarian cancer progression by establishing a procancer microenvironment. Am J Pathol. 2014; 184(8):2285-96. PMC: 4116697. DOI: 10.1016/j.ajpath.2014.05.006. View

3.
Murr C, Widner B, Wirleitner B, Fuchs D . Neopterin as a marker for immune system activation. Curr Drug Metab. 2002; 3(2):175-87. DOI: 10.2174/1389200024605082. View

4.
Mitsutake N, Namba H, Takahara K, Ishigaki K, Ishigaki J, Ayabe H . Tie-2 and angiopoietin-1 expression in human thyroid tumors. Thyroid. 2002; 12(2):95-9. DOI: 10.1089/105072502753522310. View

5.
Buffa F, Camps C, Winchester L, Snell C, Gee H, Sheldon H . microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res. 2011; 71(17):5635-45. DOI: 10.1158/0008-5472.CAN-11-0489. View